Skip to main content
letter
. 2020 May 14;81(2):e86–e88. doi: 10.1016/j.jinf.2020.05.024

Table 2.

Clinical findings according to the short-term outcomes.

Discharged Not discharged Died Total
N 7 18 6 31
Male 5 (71.4) 10 (55.5) 4 (66.7) 19 (61.3)
Median age 71 (68–72) 81 (77.7–85.5) 77.5 (72–91) 74 (71–81)
65–70 2 (28.5) 3 (16.6) 1 (16.6) 6 (19.3)
71–74 4 (57.1) 5 (27.7) 2 (33.3) 11 (35.4)
75–80 1 (14.2) 4 (22.2) 0 5 (16.1)
81–89 0 5 (27.7) 1 (16.6) 6 (19.3)
≥ 90 0 1 (5.5) 2 (33.3) 3 (9.6)
≥ Two comorbidities 6 (85.7) 13 (72.2) 5 (83.3) 24 (77.4)
Severe Pneumonia 6 (85.7) 15 (83.3) 6 (100) 27 (87)
Patients requiring Oxygen supplement 6 (85.7) 16 (88.8) 6 (100) 28 (90.3)
Low flow (nasal cannula/simple mask) 3 (42.8) 7 (38.8) 0 10 (32.2)
High flow (Venturi or reservoir masks) 2 (28.5) 6 (33.3) 2 (33.3) 10 (32.2)
Non invasive-ventilation 0 0 0 0
Invasive Ventilation 1 (14.2) 3 (16.6) 4 (66.7) 8 (25.8)
Transferred to the ICU 1* (14.2) 3 (16.6) 4 (66.7) 8 (25.8)
baseline qSOFA score ≥ 2 0 3 (16.6) 2 (33.3) 5 (16.1)
baseline SOFA score ≥ 2 4 (57.1) 8 (44.4) 5 (83.3) 17 (54.3)
Severe clinical events 7 7 14 28
ARDS 2 (28.5) 3 (16.6) 6 (100) 11 (35.4)
Septic shock 0 0 3 (50) 3 (9.6)
Secondary infections 3 (42.8) 4 (22.2) 2 (33.3) 9 (29.1)
Acute hearth injury 0 0 1 (16.6) 1 (3.2)
Multiple organ failure 0 0 2 (33.3) 2 (6.4)
Pancreatitis 2 (28.5) 0 0 2 (6.4)
Duration of hospital stay 23 (21–33) 27.5 (20.5–32) 12 (5.7–17) 23 (16–30)

Abbreviations: ARDS, acute respiratory distress disease.